drugset / Trial / NCT03044041

Comparison Between Low Dose and High Dose Intra-articular Tranexamic Acid in Total Knee Arthroplasty

NCT03044041 ↗

Phase 4 Completed 80 enrolled Thammasat University
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to compare blood loss between using low dose (500 mg) and high dose (3 g) topical intra-articular tranexamic acid after total knee arthroplasty in double-blind RCT

Timeline

Start
2016-01
Primary completion
2017-01
Completion
2017-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 500 mg Other
Subject Tranexamic Acid Small molecule 3 g Other

Indications

No indication recorded.